SCHEMBL4751176

SCHEMBL4751176

CC12CC3CC(C)(C1)CC(Oc1cccc4c1C(=O)NC4=O)(C3)C2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.37
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
GAA P10253 1/20 0.35
CASP3 P42574 4/20 0.33
PARP1 P09874 2/20 0.32
MEN1 O00255 1/20 0.32
RGS12 O14924 1/20 0.32
USP2 O75604 1/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
CYP2C9 P11712 1/20 0.32
APEX1 P27695 1/20 0.32
CASP1 P29466 1/20 0.32
BRCA1 P38398 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10441891 0.70 ALDH1A1 (0.39) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL29378366 0.68 TOP1 (0.55) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL9768590 0.68 KDM4E (0.51) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL384815 0.68 TOP1 (0.55) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL4751174 0.68 EPHX2 (0.41) GPR84KDM4EALDH1A1HPGDGAA
SCHEMBL262473 0.68 GSK3B (0.50) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL28099802 0.68 GSK3B (0.50) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL1027363 0.66 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10GAA
Hydrochloric Acid SCHEMBL15251326 0.66 SLC6A2 (0.46) GSK3B
SCHEMBL30830712 0.65 HRH1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008135041-A1 ADAMANTYLOXYAMINE DERIVATIVES AND RELATED COMPOUNDS FOR USE AS NMDA AND/OR DPP-4 MODULATORS FOR THE THERAPY OF CNS DISEASES AND DIABETES SCHEBO BIOTECH AG (DE) 2008-11-13 WO disclosed